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Abstracts / International Journal of Surgery 23 (2015) S15eS134 S23Results: 76 patients underwent lung resection in the year prior to the ERP
and 80 patients in the following year. Median agewas 72 years (IQR 64-77)
and 69 years (IQR 64-75) before and after programme commencement,
respectively (p ¼ 0.120). The proportion of patients undergoing VATS
resectionwas 55.3% and 66.3% in the consecutive years (p¼ 0.160). LOS for
all approaches prior to and following the introduction of ERP was 6 days
(IQR 4-8) versus 5 days (IQR 3-8), respectively (p ¼ 0.126). The non-sig-
niﬁcant reduction in LOS was observed in both open and VATS cases.
Overall, the reduction in LOS represented a cost reduction of £26880(14%).
Conclusion: The beneﬁts of a thoracic surgery ERP may be difﬁcult to
measure in terms of hard end-points due to the staged nature of ERP
implementation. A trend towards reduced LOS was observed following the
introduction of the thoracic surgery ERP.
0308: A PROGNOSTIC INDICATOR IN RECTAL CANCER SURGERY: LYMPH
NODE RATIO IN NEO-ADJUVANT CHEMO-RADIOTHERAPY (CRTX)
K. Ong 1,2,*, S.S. Fong 1,2, G.S. Tay 1,2. 1University of Glasgow, UK; 2 Tan Tock
Seng Hospital, Singapore
Aim: This study aims to identify which variables -lymph node yield (LNY),
LN ratio (LNR) and LN involvement (LNI)- are signiﬁcant predictors of
overall survival (OS) in patients who had neo-adjuvant CRTx for rectal
cancer.
Methods: This is a retrospective study of patients who had surgical
resection for rectal cancers from January 2006-December 2011 in TTSH
(Singapore). LNY, LNI and LNR from histopathology are recorded. Corre-
lation and multiple regression analyses were conducted to examine rela-
tionship between OS (3-year follow-up) and potential predictors (LNY,
LNI, and LNR).
Results: A total of 200 patients were included, of which 80 had neo-
adjuvant CRTx. A reduction in mean LNY and LNI were found in the neo-
adjuvant group (from 23.4 to 15.0, p < 0.01 and 3.45 to 1.86, p ¼ 0.163
respectively). There was no reduction in mean LNR (both 0.11). OS is
negatively and signiﬁcantly correlated with LNI (p ¼ 0.019) and LNR
(p ¼ 0.011). The stepwise multiple regression model showed LNR as best
predictor of survival (R2 ¼ 0.072, F (1, 71) ¼ 5.495, p < 0.05).
Conclusion: Neo-adjuvant CRTx reduces LNYand LNI but not LNR. LNI and
LNR are inversely related to OS. LNR is the single best predictor of prog-
nosis for patients who had neo-adjuvant CRTx for rectal cancer.
0339: A COMPARISON OF TWO DIGITAL MAMMOGRAPHY SYSTEMS AT
BREAST TEST WALES e WHAT DOES IT MEAN FOR SURGEONS?
G. Devonish, T. Evans*, B. Burlton, D. Bailey, K. Gower-Thomas. Breast Test
Wales, UK
Aim: The Welsh breast screening service converted to wholly digital
technology in 2012. This study aims to compare the performance of the
two digital mammography technologies used (Sectra/Philips and Hologic);
speciﬁcally number, type, size and grade of tumour identiﬁed?
Methods: A retrospective study of a prospectively collected database of
50,000 consecutive screening episodes; clients aged 49-88 (mean 61.9). All
tumours were deﬁned by type, size, grade and invasive or non invasive
(DCIS). Performance was analysed for statistically signiﬁcant differences.
Results: 500 cancers were found with no statistical difference in invasive
cancer detection nor between ductal or lobular subtypes. Hologic detected
267 tumours, 72 (26.97%)wereDCIS (2.88 per 1000), compared to Sectrawith
233 cancers overall including 36 (15.45%)DCIS (1.44 per 1000). The difference
in DCIS detection was signiﬁcant p  0.001 with both showing 53% HNG le-
sions. Therewasnosigniﬁcantdifference inDCISsize for the twotechnologies.
Conclusion: Hologic and Sectra/Philips seem comparable in terms of
invasive cancer detection, with a statistically signiﬁcant difference in DCIS
detection, not reported in previous studies. IF this difference is clinically
signiﬁcant we may perform unwarranted surgery on many women.
0353: NUTRITIONAL ENHANCED RECOVERY: POST-PYLORIC FEEDING
AFTER DISCHARGE FOLLOWING OESOPHAGECTOMY
R.C. McLean*, J. Sturrock, H. Jaretzke, L. Jones. Royal Victoria Inﬁrmary, UKAim: Oesophagectomy is associated with pre- and postoperative nutri-
tional difﬁculties, including protein-energy malnutrition (deﬁned as >10%
weight loss). Postoperative nutritional enhanced recovery (NER) aims to
optimise nutrition with early reintroduction of enteral feeding by post-
pyloric feeding (nasojejunal tube or surgical jejunostomy) and a period of
overnight enteral feeding following discharge.
Methods: To investigate the postoperativeweight changes in patients who
received NER and thosewho did not, this retrospective audit reviewed case
notes for 214 patients who underwent oesophagectomy between 1st
January 2012 and 30th April 2014.
Results: Patients who had post-pyloric feeding continued following
discharge (N ¼ 32) had signiﬁcantly less weight loss from discharge until
3-months postoperatively compared to those with no supplementary
feeding (4.6 kg [5.4%] vs. 12.3 kg [13.8%], p < 0.001). Weight loss in
the post-pyloric feeding cohort was shown to increase following cessation
of feeding (median duration postoperatively: 82 days [22e181]) however
there remained a signiﬁcant difference at 6-months (8.05 kg [10.6%] vs.
13.1 kg [14.8%], p ¼ 0.007) and by 12-months there was no signiﬁcant
difference (11.3 kg [14.1%] vs. 11.2 kg [14.0%], p ¼ 0.505).
Conclusion: Oesophagectomy is shown to be associated with substantial
postoperative protein-energy malnutrition. Postoperative weight loss and
malnutrition can be signiﬁcantly reduced with post-pyloric feeding
following discharge, and this audit supports NER implementation.
0532: PERINEURAL INVASION AND NEUROPATHY IN PANCREATIC
CANCER: FROM HUMAN TISSUES TO A CELLULAR MODEL
W. Alrawashdeh 1,*, R. Jones 2, N. Wijesuriya 3, T. Crnogorac-
Jurcevic 1. 1Barts Cancer Institute, UK; 2MS Bioworks Ann Arbor, USA;
3Royal London Hospital, UK
Aim: Perineural invasion (PNI) is a common and characteristic feature of
pancreatic ductal adenocarcinoma (PDAC). It is associated with poor
prognosis, tumour recurrence and generation of pain. The molecular al-
terations underlying the neuro-epithelial interactions in PNI are poorly
understood.
Methods: We performed Mass Spectrometry-based global proteomic
proﬁling of laser microdissected PNI and non-PNI cancer, as well as
invaded and non-invaded nerves from PDAC tissues. An in vitro model of
PNI was developed using a co-culture system comprising PC12 cells, a rat
pheochromocytoma cell line, as the neuronal element and PDAC cells.
Results: The overall proteomic proﬁles of PNI and non-PNI cancer appeared
largely similar. In contrast, nerve samples demonstrated widespread mo-
lecular alterations characteristic of neuronal plasticity upon invasion by
cancer cells. Immunohistochemistry conﬁrmed the up-regulation of VGF in
invaded compared to non-invaded nerves. Using the in vitro co-culture
model, PDAC cell lines were able to induce PC12 cells neuronal plasticity
including survival, neurite extension as well as VGF expression.
Conclusion: The proteomic data indicates a molecular pattern consistent
with neuronal injury and provides potential molecular mechanisms for the
widespread neuronal plasticity in PNI. The unique in vitro model re-
capitulates these changes and provides a versatile tool to investigate their
roles.
0623: PATTERNS OF MELANOMA RECURRENCE FOLLOWING A
NEGATIVE SENTINEL LYMPH NODE BIOPSY
E. O'Connell*, P. O'Leary, Z. Khan, K. Fogarty, P. Redmond. Cork University
Hospital, Ireland
Aim: Sentinel lymph node (SLN) status is a recognised prognostic indi-
cator in melanoma. However, in the setting of a negative SLN there re-
mains a high risk of disease recurrence. We aimed to analyse the
predictors and patterns of recurrence in patients with a negative SLN
biopsy.
Methods: Review of a prospectively maintained melanoma database. Pa-
tients with a negative sentinel lymph node were identiﬁed and we per-
formed statistical analysis on their demographics, tumour histology
characteristics and follow-up data.
Results: Of 164 patients studied, 40 (23%) had a recurrence of melanoma at
amedian of 39.5 months following diagnosis (range 1e92months). Distant
